Original language | English |
---|---|
Pages (from-to) | 3189-3193 |
Number of pages | 5 |
Journal | Blood Advances |
Volume | 6 |
Issue number | 10 |
DOIs | |
State | Published - May 24 2022 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Blood Advances, Vol. 6, No. 10, 24.05.2022, p. 3189-3193.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome
AU - Güney, Ekin
AU - Lucas, Calixto Hope G.
AU - Qi, Zhongxia
AU - Yu, Jingwei
AU - Zhang, Ruth
AU - Ohgami, Robert S.
AU - Rubenstein, James L.
AU - Boué, Daniel R.
AU - Schafernak, Kristian
AU - Wertheim, Gerald B.
AU - Dahiya, Sonika
AU - Giulino-Roth, Lisa
AU - Attarbaschi, Andishe
AU - Barth, Matthew J.
AU - Kothari, Shalin
AU - Abla, Oussama
AU - Cohen, Adam L.
AU - Mendez, Joe S.
AU - Bollen, Andrew
AU - Perry, Arie
AU - Tihan, Tarik
AU - Pekmezci, Melike
AU - Solomon, David A.
AU - Wen, Kwun Wah
N1 - Funding Information: This study is supported by the Clinical Research Endowment Grant and Rebecca Frankel Award from the University of California San Francisco, Department of Pathology to K.W.W. D.A.S. is supported by the Morgan Adams Foundation and the NIH Director’s Early Independence Award (DP5 OD021403). J.L.R. is supported by Leukemia and Lymphoma Society and NIH R01CA139-83-01A1 and R01CA239462 grants. C.-H.G.L. is supported by the UCSF Training Program in Translational Brain Tumor Research, National Institutes of Health (NIH), National Cancer Institute Grant T32CA151022.
PY - 2022/5/24
Y1 - 2022/5/24
UR - http://www.scopus.com/inward/record.url?scp=85130912879&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2021006018
DO - 10.1182/bloodadvances.2021006018
M3 - Letter
C2 - 35157770
AN - SCOPUS:85130912879
SN - 2473-9529
VL - 6
SP - 3189
EP - 3193
JO - Blood Advances
JF - Blood Advances
IS - 10
ER -